sulconazole has been researched along with Cancer of Esophagus in 1 studies
sulconazole: RN given refers to cpd with unspecified isomeric designation; structure given in first source
sulconazole : A racemate comprising equimolar amounts of (R)- and (S)-sulconazole. An antifungal agent with activity against Candida species, it is used (generally as the nitrate salt) for the topical treatment of fungal skin infections.
1-{2-[(4-chlorobenzyl)sulfanyl]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole : A member of the class of imidazoles that is 1-ethyl-1H-imidazole in which one of the hydrogens of the methyl group is replaced by a (4-chlorobenzyl)sulfanediyl group while a second is replaced by a 2,4-dichlorophenyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Esophageal cancer is the seventh most common cancer in the world." | 1.91 | Sulconazole Induces PANoptosis by Triggering Oxidative Stress and Inhibiting Glycolysis to Increase Radiosensitivity in Esophageal Cancer. ( Deng, DX; Heng, JH; Li, EM; Liao, LD; Lin, W; Liu, LX; Xu, LY; Xu, XE; Zhao, H; Zheng, ZY, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, LX | 1 |
| Heng, JH | 1 |
| Deng, DX | 1 |
| Zhao, H | 1 |
| Zheng, ZY | 1 |
| Liao, LD | 1 |
| Lin, W | 1 |
| Xu, XE | 1 |
| Li, EM | 1 |
| Xu, LY | 1 |
1 other study available for sulconazole and Cancer of Esophagus
| Article | Year |
|---|---|
Sulconazole Induces PANoptosis by Triggering Oxidative Stress and Inhibiting Glycolysis to Increase Radiosensitivity in Esophageal Cancer.
Topics: Apoptosis; Cell Line, Tumor; Esophageal Neoplasms; Glycolysis; Humans; Oxidative Stress; Proteomics; | 2023 |